Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1995 Mar 25;310(6982):752–754. doi: 10.1136/bmj.310.6982.752

Misleading meta-analysis.

M Egger, G D Smith
PMCID: PMC2549158  PMID: 7711568

Full text

PDF
752

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antman E. M., Lau J., Kupelnick B., Mosteller F., Chalmers T. C. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA. 1992 Jul 8;268(2):240–248. [PubMed] [Google Scholar]
  2. Chalmers I., Dickersin K., Chalmers T. C. Getting to grips with Archie Cochrane's agenda. BMJ. 1992 Oct 3;305(6857):786–788. doi: 10.1136/bmj.305.6857.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Egger M., Smith G. D. Magnesium and myocardial infarction. Lancet. 1994 May 21;343(8908):1285–1285. [PubMed] [Google Scholar]
  4. Gøtzsche P. C. Reference bias in reports of drug trials. Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):654–656. [PMC free article] [PubMed] [Google Scholar]
  5. Levy G. Publication bias: its implications for clinical pharmacology. Clin Pharmacol Ther. 1992 Aug;52(2):115–119. doi: 10.1038/clpt.1992.119. [DOI] [PubMed] [Google Scholar]
  6. Pereira D., Pereira T. G., Rabaçal C., Carvalho E., Linder J., Afonso J. S., Pereira J. N., Halpern M. J., Fernandes J. S. Efeito da administraço de SO4Mg por via intra-venosa na fase aguda do enfarte do miocárdio. Rev Port Cardiol. 1990 Mar;9(3):205–210. [PubMed] [Google Scholar]
  7. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992 Jul 4;305(6844):15–19. doi: 10.1136/bmj.305.6844.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Shechter M., Hod H., Chouraqui P., Kaplinsky E., Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol. 1995 Feb 15;75(5):321–323. doi: 10.1016/s0002-9149(99)80546-3. [DOI] [PubMed] [Google Scholar]
  9. Thögersen A. M., Johnson O., Wester P. O. Effects of magnesium infusion on thrombolytic and non-thrombolytic treated patients with acute myocardial infarction. Int J Cardiol. 1993 Apr;39(1):13–22. doi: 10.1016/0167-5273(93)90292-o. [DOI] [PubMed] [Google Scholar]
  10. Yusuf S., Collins R., MacMahon S., Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet. 1988 May 14;1(8594):1088–1092. doi: 10.1016/s0140-6736(88)91906-x. [DOI] [PubMed] [Google Scholar]
  11. Yusuf S., Flather M. Magnesium in acute myocardial infarction. BMJ. 1995 Mar 25;310(6982):751–752. doi: 10.1136/bmj.310.6982.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]
  13. Yusuf S., Teo K., Woods K. Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention. Circulation. 1993 Jun;87(6):2043–2046. doi: 10.1161/01.cir.87.6.2043. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES